| dMMR/MSI-H | dmmr, msi h, msi high |
| pMMR/MSS | pmmr, mss, microsatellite stable |
| Ph+ acute lymphoblastic leukaemia | ph+ all, ph positive all, philadelphia positive all, ph+ b all |
| HER2-low | her2 low, her2low |
| HER2-ultralow | her2 ultralow |
| Extensive-stage SCLC | es sclc, extensive stage sclc, extensive stage small cell lung cancer, extensive disease sclc |
| Limited-stage SCLC | ls sclc, limited stage sclc, limited stage small cell lung cancer, limited disease sclc |
| HR-positive breast cancer | luminal |
| Triple-positive breast cancer | triple positive |
| Stage III | stage iii, stage iiia, stage iiib, stage iiic, stage 3, stage 3a, stage 3b, stage 3c |
| RAS wild-type | ras wt, ras wild type, ras wildtype, ras negative |
| KRAS G12C | kras g12c, g12c |
| Lynch syndrome (dMMR) | lynch syndrome, lynch |
| Follicular thyroid cancer | follicular thyroid cancer, follicular thyroid carcinoma, ftc, hurthle cell carcinoma, hurthle, oncocytic thyroid carcinoma |
| Ph-negative (BCR::ABL1) | ph negative, ph neg, philadelphia negative, philadelphia chromosome negative |
| Oesophageal squamous cell carcinoma | escc, esophageal squamous cell carcinoma, oesophageal squamous cell carcinoma, esophageal scc, oesophageal scc |
| Oesophageal adenocarcinoma | eac, esophageal adenocarcinoma, oesophageal adenocarcinoma |
| Lung adenocarcinoma | lung adenocarcinoma, adenocarcinoma of the lung, nsclc adenocarcinoma |
| Squamous NSCLC | squamous nsclc, nsclc squamous, squamous lung cancer, squamous cell lung cancer, lung squamous cell carcinoma, squamous cell carcinoma of the lung |
| Non-squamous NSCLC | non squamous nsclc, nonsquamous nsclc, nsclc non squamous, nsclc nonsquamous, non squamous lung cancer |
| Clear cell renal cell carcinoma | ccrcc, cc rcc |
| Non-clear cell renal cell carcinoma | nccrcc, non clear cell rcc |
| Papillary renal cell carcinoma | prcc |
| High-grade serous ovarian cancer | hgsoc |
| Low-grade serous ovarian cancer | lgsoc |
| Differentiated thyroid cancer | dtc |
| Papillary thyroid cancer | ptc |
| Medullary thyroid cancer | mtc |
| Lymphoma | lymphoma, lymphomas |
| Non-Hodgkin lymphoma | nhl, non hodgkin, non hodgkin lymphoma, non hodgkin lymphomas, non hodgkin's lymphoma, non hodgkins lymphoma |
| B-cell lymphoma | b cell lymphoma, b cell lymphomas, b nhl, b cell nhl, b cell non hodgkin lymphoma |
| Leukaemia | leukaemia, leukemia, leukaemias, leukemias |
| Acute leukaemia | acute leukaemia, acute leukemia |
| Chronic leukaemia | chronic leukaemia, chronic leukemia |
| FGFR1 | fgfr1, fgfr 1 |
| FGFR2 | fgfr2, fgfr 2 |
| FGFR3 | fgfr3, fgfr 3 |
| FGFR4 | fgfr4, fgfr 4 |
| IDH1 | idh1, idh 1 |
| IDH2 | idh2, idh 2 |
| PDGFRA | pdgfra, pdgfr a, pdgfralpha, pdgfr alpha, pdgfrα, pdgfr α |
| PDGFRB | pdgfrb, pdgfr b, pdgfrbeta, pdgfr beta, pdgfrβ, pdgfr β |
| Gastro-oesophageal junction adenocarcinoma | gej, gej adenocarcinoma, gej cancer, gastro oesophageal junction, gastroesophageal junction, gastro esophageal junction, gastro oesophageal junction adenocarcinoma, gastroesophageal junction adenocarcinoma, gastro oesophageal junction cancer, gastroesophageal junction cancer, junctional adenocarcinoma |
| Cholangiocarcinoma | cholangiocarcinoma, cca, intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, bile duct cancer |
| Gallbladder cancer | gallbladder, gallbladder cancer, gallbladder carcinoma, gall bladder cancer |
| Pancreatic NET | pnet, pnets, pannet, pancreatic net, pancreatic nets, pancreatic neuroendocrine tumour, pancreatic neuroendocrine tumor, pancreatic neuroendocrine tumours, pancreatic neuroendocrine neoplasm |
| Gastrointestinal NET | gi net, gastrointestinal net, gastrointestinal neuroendocrine tumour, gastrointestinal neuroendocrine tumor, midgut net, small intestinal net, intestinal net, si net |
| Lung NET | lung net, lung nets, lung neuroendocrine tumour, lung neuroendocrine tumor, lung carcinoid, bronchial carcinoid, pulmonary carcinoid, typical carcinoid, atypical carcinoid, bronchopulmonary net |
| Castration-resistant prostate cancer | crpc, castration resistant prostate cancer, castrate resistant prostate cancer |
| mCRPC | mcrpc, metastatic castration resistant prostate cancer |
| nmCRPC | nmcrpc, nm crpc, non metastatic castration resistant prostate cancer |
| Hormone-sensitive prostate cancer | hspc, cspc, hormone sensitive prostate cancer, castration sensitive prostate cancer |
| mHSPC | mhspc, mcspc, metastatic hormone sensitive prostate cancer, metastatic castration sensitive prostate cancer |
| nmHSPC | nmhspc, non metastatic hormone sensitive prostate cancer |
| NMIBC | nmibc, non muscle invasive bladder cancer, non muscle invasive |
| MIBC | mibc, miuc, muscle invasive bladder cancer, muscle invasive urothelial carcinoma, muscle invasive |
| Low-grade glioma | low grade glioma, lgg, plgg, paediatric low grade glioma, pediatric low grade glioma, pilocytic astrocytoma |
| High-grade glioma | high grade glioma, hgg, glioblastoma, gbm, astrocytoma grade 4, grade 4 astrocytoma, diffuse midline glioma, dipg |
| SEGA | sega, subependymal giant cell astrocytoma |
| Pleural mesothelioma | pleural mesothelioma, malignant pleural mesothelioma, mpm |
| Peritoneal mesothelioma | peritoneal mesothelioma, malignant peritoneal mesothelioma |
| DFSP | dfsp, dermatofibrosarcoma, dermatofibrosarcoma protuberans |
| Acute promyelocytic leukaemia | apl, acute promyelocytic leukaemia, acute promyelocytic leukemia |
| t-AML or AML-MRC | t aml, therapy related aml, therapy related acute myeloid leukaemia, therapy related acute myeloid leukemia, aml mrc, secondary aml, aml with myelodysplasia related changes |
| Chronic phase CML | cp cml, cml cp, chronic phase cml |
| Myelofibrosis | myelofibrosis, primary myelofibrosis, pmf, post pv myelofibrosis, post et myelofibrosis, secondary myelofibrosis |
| Polycythaemia vera | polycythaemia vera, polycythemia vera, polycythaemia, polycythemia |
| Essential thrombocythaemia | essential thrombocythaemia, essential thrombocythemia |
| HES or CEL | hes, hypereosinophilic syndrome, cel, chronic eosinophilic leukaemia, chronic eosinophilic leukemia |
| Advanced systemic mastocytosis | advanced systemic mastocytosis, advsm, aggressive systemic mastocytosis, asm, sm ahn, systemic mastocytosis with associated haematological neoplasm, mast cell leukaemia, mast cell leukemia |
| Indolent systemic mastocytosis | indolent systemic mastocytosis, ism, smouldering systemic mastocytosis, smoldering systemic mastocytosis |
| Smouldering myeloma | smouldering myeloma, smoldering myeloma, smouldering multiple myeloma, smoldering multiple myeloma, smm |
| B-cell ALL | b all, bcp all, b cell all, b cell precursor all, b cell precursor acute lymphoblastic leukaemia, b cell acute lymphoblastic leukaemia, b lbl |
| T-cell ALL | t all, t cell all, t cell acute lymphoblastic leukaemia, t lbl, t lymphoblastic lymphoma |
| Classical Hodgkin lymphoma | chl, classical hodgkin lymphoma, classical hodgkin |
| NLPHL | nlphl, nlpbl, nodular lymphocyte predominant hodgkin lymphoma, nodular lymphocyte predominant b cell lymphoma |
| DLBCL | dlbcl, dlbcl nos, diffuse large b cell lymphoma |
| HGBL | hgbl, high grade b cell lymphoma, double hit lymphoma, triple hit lymphoma |
| PMBCL | pmbcl, primary mediastinal large b cell lymphoma, primary mediastinal b cell lymphoma |
| FL grade 3B | fl3b, fl grade 3b, grade 3b follicular lymphoma, follicular lymphoma grade 3b |
| Cutaneous T-cell lymphoma | ctcl, cutaneous t cell lymphoma, cutaneous lymphoma, mycosis fungoides, sezary syndrome, sezary |
| Systemic T-cell lymphoma | ptcl, systemic t cell lymphoma, peripheral t cell lymphoma, alcl, anaplastic large cell lymphoma, systemic alcl, systemic anaplastic large cell lymphoma |
| Platinum-sensitive | platinum sensitive, platinum sensitive relapse, platinum sensitive relapsed, platinum sensitive recurrent |
| Platinum-resistant | platinum resistant, platinum refractory |